SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1

Acta Pharmaceutica Sinica B · Published 2026-07-01 · DOI 10.1016/j.apsb.2026.07.042

Free full text

Authors (16)

Liubing Du, Mengxuan Wang, Xue Liu, Ziliang Peng, Zhihui Zhang, Zhanjia Zhang, Zhijuan Liang, Qingrong Sun, Jiaxin Zhuang, Kongyang Ma, Yao-Qing Chen, Panpan Hou, Hua Zhang, Deyin Guo, Ji-An Pan, Xiaoxue Peng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Du, L., Wang, M., Liu, X., et al. (2026). SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.07.042

Related articles